Hennion & Walsh Asset Management’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Hennion & Walsh Asset Management’s Portfolio INBX Stock Details INBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-30,561	Closed	-$1.07M	–	910
2024 Q1	$1.07M	Buy	30,561 +744	+2%	+$27.1K	0.06%	404
2023 Q4	$1.13M	Buy	29,817 +2,086	+8%	+$44.7K	0.06%	376
2023 Q3	$509K	Buy	27,731 +13,098	+90%	+$274K	0.03%	511
2023 Q2	$380K	Buy	+14,633	New	+$342K	0.02%	595

Other funds holding INBX

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Hennion & Walsh Asset Management's INBX Position: Q2 2024 in Review

Hennion & Walsh Asset Management sold out of Inhibrx, Inc. Common Stock (INBX) in Q2 2024, closing a stake of 30,561 shares — an estimated $1.07M sold.

Hennion & Walsh Asset Management first reported a position in INBX in Q2 2023 and held it in 4 quarters. The position peaked at $1.13M in Q4 2023. 2 funds tracked by Wall St. Rank hold INBX as of Q2 2024.

Hennion & Walsh Asset Management reported no remaining Inhibrx, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Hennion & Walsh Asset Management sold 30,561 Inhibrx, Inc. Common Stock shares in Q2 2024, an estimated $1.07M.
Hennion & Walsh Asset Management first reported a position in Inhibrx, Inc. Common Stock in Q2 2023 and held it in 4 quarters.
Hennion & Walsh Asset Management's Inhibrx, Inc. Common Stock position peaked at $1.13M in Q4 2023.
2 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q2 2024.

Based on Hennion & Walsh Asset Management's 13F filing for Q2 2024, filed 19 Jul 2024.